Dear Researcher,

        When you fill out the form,  related article will be sent to you automatically as PDF file.

       Thanks for your interest and cooperation.

Article # : SC38

Sema Çalış, Ph.D.

Professor

 

In vitro and in vivo studies of ibuprofen-loaded biodegradable alginate beads

 

 

B.ARICA1, S.CALIS1, P.ATILLA2, N.T.DURLU3, N.CAKAR3, H.S.KA S 2 & A.A.HINCAL1

 

1Department of Pharmaceutical Technology,Faculty of Pharmacy, 2Department of Histology and

Embryology, Faculty of Medicine,and 3Department of Pharmacology, Faculty of Pharmacy,

University of Hacettepe, 06100, Ankara, Turkey

 

Summary

The irritation effects of ibuprofen, a widely used non-steroidal anti-inflammatory drug (NSAID), were evaluated on mouse gastric and duodenal mucosa when suspended in 0.5%(w/v) sodiumcarboxymethylcellulose (NaCMC) solution and loaded in alginate beads. The ionotropic gelation method was used to prepare controlled release alginate beads of ibuprofen.The influence of various formulation factors on the encapsulation efficiency, as in vitro drug release and micromeritic properties, was investigated.Other variables included the alginate concentration,  percentage drug loading and stirring speed during the microencapsulation process.Scanning electron micrographs of alginate beads loaded with ibuprofen showed rough surface morphology and particle sizes in the range of 1.15±0.4–3.15±0.6 mm. The yield of microspheres, as collected after drying, was generally 80–90%. Formulation code H showing t50% value of 3.5 h was chosen for in vivo trials because of the appropriate drug release properties. For in vivo trials, free ibuprofen (100 mg kg1), blank and ibuprofen (100 mgkg1) loaded alginate beads (formulation code H) were suspended in 0.5%(w/v) NaCMC solution and each group was given to six mice orally by gavage. NaCMC solution was used as a control in experimental studies. In vivo data showed that the administration of ibuprofen in alginate beads prevented the gastric lesions.

 

Keywords

Alginate beads, ibuprofen, microencapsulation, controlled release, gastric lesions

 

×× Back to Articles&Proceedings